The Eponymous Lecture to honour Viscount Nuffield was founded on his 80th birthday. It is a privilege to be invited to deliver this, the third Lecture.
I thank the President and Officers of the Society, who have thought me worthy of this honour but I appreciate that they have also laid upon me the duty to fulfil the dual purpose for which it was founded, firstly to pay a tribute, on behalf of the medical profession, to Lord Nuffield whose generosity and princely benefactions to the profession have never been surpassed or equalled and secondly to deliver a lecture devoted to the advancement of the science and art of medicine.
I have chosen 'Cancer' as my subject; not in the sense limited by pathology or therapy, but as an aberration of normal biology to which there is no complete answer as regards cause or cure.
I will spare you all statistics, not because I do not value their importance, but as my main concern is to paint a very broad picture of this disease, which in the Concise Oxford Dictionary is recorded as the figurative equivalent of 'Evil', and to draw attention to the implications as regards the patient's mind and the doctor's problems.
As a country, we have the unenviable distinction of the highest cancer mortality; this does not really mean that we have the highest cancer incidence, as there are so many fallacies in the collection of data in different countries. But the incidence in England and Wales is frighteningly great and I cannot express it better or more concisely than to quote Professor David Smithers (1960) : ' In our community at present one person in every 4 or 5 born is likely to develop neoplastic disease at some period during life.' With his usual clarity of thought he adds: 'A country in which neoplastic disease is a frequent cause of death, is a country with cause to be proud of its medical service, since it is a lowered death-rate from Royal Society of Medicine >;%,.
Chairman The Rt Hon Lord Adrian OM MD FRS Meeting October 101962 " Nuffield Lecture K * other causes which permits a tumo predominance.' In other words, cancer is a disease of the healthy. The probability of acquiring cancer at the rate of one birth in four or five, the possibility of developing a malignant tumour in all tissues and every organ, the lack of immunity of any age group, the many histological types and the variability in their degree of virulence-when taken together make this a problem of formidable complexity.
If in addition it is recollected that there is a latent period, often many years, between the inception of the neoplasm and its clinical manifestations it is clear that this is no single disease process, no solitary event but some abnormality in the sequence of normal physiological processes of embryology, growth, maturation, functional activity and senescence.
A useful classification of cancers is in two groups: 'Endogenous' and 'Exogenous'. Most human cancers are endogenous; all experimentally induced cancers in animals and the accidentally and involuntarily induced cancers in man are exogenous. The few exogenous human cancers are man-produced, the well-known industrial cancers, the cancers following exposure to radioactivity. Numerically these are insignificant, mostly preventable and in fact only pointers to the possible carcinogenic agencies in our environment, resulting in some aberration in the normal chemical and hormonal processes which determine the occurrence of endogenous growths.
The Patient's Viewpoint Let us for a moment consider the average patient, be he a hospital patient in the outpatient department, or consulting his family doctor, or facing the specialist. What are the conflicting emotions which assail the man or woman, told or suspected of this, the most dreaded of mankind's afflictions? Having faced such a situation for nearly half a century, with patients of all ages, both sexes, of nearly every nationality, race, creed, colour, social status and education, and having with increasing experience as the years went by watched the patient's reactions, I can from my personal Proceedings of the Royal Society ofMedicine experience of meeting over 20,000 human beings suffering from cancer, summarize what I believe is the usual sequence of emotions.
The dominating emotion is obviously fear. With this fear as an immediate reaction is a sense of impending death, as most patients think or believe, quite erroneously, that cancer kills quickly, which of course is not necessarily true. Vaguely mixed with this feeling of being condemned to death is a sense of regret at the apparent brevity of life expectation, the regret that in the near future they will no longer be part of the pulsating rhythm of life around them. This feeling is quite distinct from the fear of death, it is the sadness at the loss of life.
Beyond this immediate and overwhelming, purely personal reaction there is, at a second emotional plane, the thought of those nearest to him or her, the effect of this illness on work and occupation and on the capacity of earning a living. This concern has no relation to the financial status of a patient; in fact the higher the social scale the greater the worry, usually from the greater commitments; and in the very highest income brackets the thought of death-duties and the panic measures to avoid or minimize them is a sobering reflection on the futility of amassing wealth.
These thoughts and emotions follow each other in the patient's mind and lead to the necessity of facing a new situation, always unexpected and perplexing. Despair, however, is not as a rule a lasting state and subconsciously there obtrudes on the patient's mind the problem of facing the new situation. The normal human instinct of self-preservation reasserts itself. It is a natural reflex that the next wave of rational thought concerns itself with the battle to be fought with this personal foe and there is born some hope that treatment and faith in supernatural or divine powers will in the end win this battle for survival. In his subconscious mind the patient tries to equate treatment with cure.
Fear of cancer may be latent and precede both the disease and the diagnosis. Fear is undoubtedly the most potent cause of the delay in seeking treatment. It is a common observation, that doctors, doctors' wives, nurses and midwives frequently delay seeking advice and surround themselves by walls of illusions, often quite irrational. Doctors and dentists have been known to observe for months their own cancer of the tongue in a mirror and call it 'lichen planus', although they may have never seen a case, and probably have not even remembered this term since their student days. Cancer of the breast is masquerading in the woman's mind as a 'sprained muscle', or the result of a blow, or associated with the meno-pause, in fact as anything and everything except the obvious. This 'pre-diagnostic' fear is often lost once the diagnosis is made clear to the patient. Fears may persist even after successful treatment; it is a fear of recurrence and according to the patient's personality is either hidden behind a veil of an ominous silence or revealed by a polysymptomatic exuberance. Fear of cancer occasionally leads to suicide even in the absence of the disease.
To try and alleviate or dispel fear is an important part of every form of treatment. A kindly sympathetic approach and an understanding of the patient's individual type of fear creates confidence in the patient's mind. This gift of inspiring confidence may not necessarily overcome the fear of the disease but helps the patient to overcome the fear of treatment. Fear of surgery, anesthesia, radiotherapy or drugs is also not infrequently a cause of delay in seeking advice. The absence of pain in the early stages of most cancers also favours delay and creates illusions: 'It is painlessit cannot be cancer'.
In considering the patient's viewpoint it is necessary to take into account the emotions of the family. These can be graded from the most agonizing feelings of the parents in the case of young children who are victims of leukemia, neuroblastoma, Wilms' tumour or osteogenic sarcoma, to the tragedies of husband and wife, often trying to conceal from each other the true nature of the disease. The wise management of the family can only be acquired in the very hard school of experience.
The Medico-legal Aspects of Cancer Before leaving the patient's viewpoint, it may be of interest to refer to some of the medico-legal aspects arising in connexion with cancer. Sequence of events looms large in the patient's mind. 'Why, how and when did I get this awful disease?' And often retrospectively there is a recollection of some event, some injury perhaps trivial and vague. But the patient or his widow fastens on to this; hence the claims for industrial compensation or pension sometimes supported by medical opinions, although not supported by facts or by the known natural history of cancer. Most such claims are based on sequence of events: 'Post hoc, propter hoc', 'I was well when I joined the Army or Navy or Air Force -I got my cancer in the Service', or 'I fell whilst at work', 'I sustained a knock or a blow on duty'. Yet these incidents may have been so slight and trivial as not to require first-aid help or interruption of work. Such claims are sometimes supported by medical opinion based, perhaps subconsciously, on sympathy or pity. Often a statement is made that the cancer was or might have been aggravated by the incident. As the cause of cancer is unknown, it cannot be said with complete accuracy what effect an accident at work had on the course of the disease. But a just assessment can be arrived at in almost every case if the available evidence is scrutinized with impartiality in the light of our knowledge of the natural history of cancer and with the law of probability as applied to the population as a whole.
The Clinician's Problems Before considering the technical management of cancer it may be of interest to refer briefly to the social aspects of the disease. Is the patient to be told? How much is he to be told? How to convey the news? It is my experience that the technical management of the patient is not only easier and simpler but more effective if the patient is made aware of the diagnosis. It is obvious that the attitude 'I never tell' is untenable, although in some cases there is no need to tell; either because the patient is already aware that he has cancer or because he or she accepts treatment: amputation of breast or arm or leg, colostomy, tracheostomy, &c., without asking the diagnosis. Neither is the attitude 'I always tell' wise or human. There are so many variables in the patient's 'mental make-up' according to race, education and character, that no rule is applicable to all. The truth can be made less unpalatable by a careful choice of words.
The Choice of the Method of Treatment Fifty years ago, when I was a medical student, the problem of cancer treatment was simpler than it is to-day. Therer was in fact only one method of treatment, surgery. It was not a question of 'operability' in the enlightened sense of the word, but of 'removability' (if I may coin a word); a tumour could be 'cut out' or it could not. Inoperability in those days was synonymous with 'untreatability'. In my time, radiotherapy, hormone therapy and chemotherapy have been added to our weapons to deal with cancer. An inoperable tumour can be treated, often effectively, by means other than the knife, and in some patients a selective choice of a combination of two or more methods of treatment is available. A clinician confronted with the problem of how to treat a cancer patient, be he the family doctor, surgeon, radiotherapist or other specialist, should ask himself this fundamental question: 'What is the relative value of the various available methods of treatment in this particular patient?' Our duty is not only to follow the law of probability that this, that or other therapeutic measure is likely to achieve the greatest number of fiveor ten-year survivals in the majority of patients. The clinician should divorce himself from his own specialty, he should for a moment cease to be 'surgeon', 'physician', 'radiotherapist', but be a doctor in the clinical sense of the word. Each patient is an individual problem, each tumour is a biological enigma. Age, stage of disease, type of tumour, general state of health, should be taken into consideration and estimated not only as regards the chances of success to control the tumour but also in relation to the degree of disability inflicted by treatment and how such disabilities will affect the individual patient. Neither should it be forgotten that in no given case can it be predicted with accuracy if the treatment is likely to be curative or only palliative. Clinical assessment is difficult as the important factor of tumour-host relationship is not easily determined although it influences the course of the disease more than the more obvious factors of the stage of the disease, rate of growth, histological type ard anatomical site.
Were it possible to lose sight of the side-effects of major therapeutic procedures, of the physical mutilations and functional disabilities, of the mental agonies and psychological disturbances, and consider treatment solely as a technical problem with the object of achieving a certain end-result, the decision would be relatively easy.
But if preservation of life is to be gained at the price of social unacceptability, or a perpetual revolt of the patient against his physical state, victory against death is no victory for life, victory is a punishment.
The choice of treatment should therefore not be determined solely by statistical evaluation of a probability of cure in relation to various forms of treatment.
I would like to emphasize that the accuracy of statistical evaluation relates, strictly speaking, to cohorts and not to the individual. A devoted and distressed husband whose wife has cancer of the breast is not concerned with the percentage of fiveor ten-year survivals in cohorts. He has no harem of a hundred wives of a certain age group all suffering from the same cancer. To him 100% success or 100% failure relates to the one and only wife he has.
This aspect should not be lost sight of in the management of cancer patients and it is this which makes me personally not in sympathy with the 'at random' selection, now somewhat in vogue.
Prognosis
Prognosis is not quite the simple matter of correlating age, histology, extent of disease and apparent adequacy of treatment. Although spontaneous regression of tumours does occur, albeit exceptionally, spontaneous remission is much more frequently seen. They are well known to occur in malignant melanoma and in Hodgkin's disease and often there is a periodicity of activity and remission in other tumours both primary and metastatic. What is not yet widely known or generally accepted is that the rate of growth and the spread of cancer can be actively promoted by the therapeutic measure used for its control. There is nevertheless very little doubt that surgery can precipitate local recurrence and hasten dissemination, that radiotherapy by local tissue damage can lower the local resistance and that hormonal or chemical changes can lower the general resistance or stimulate the rate of growth and enhance dissemination.
I will now review some of my thoughts, ideas, and beliefs on the limitations of surgery, the achievements of radiotherapy, the promise of chemotherapy and the fascination of hormone therapy. I will review this from my own personal experience and convictionsa kind of philosophical 'credo', not technical, statistical or didactic. Some of you may disagree, others disbelieve and some others may think me presumptuous to air my views so nakedly. But if my remarks are provocative, I hope they will provoke thought and criticism and not indifference or denial in anger.
The Achievement and the Limitation of Surgery Adequate surgical excision in suitable cases eradicates the tumour in a proportion of patients. The prognosis, however, does not always depend on the length of history or even the stage of the disease; the histological variety is of a greater prognostic significance. Control of the disease may have been obtained for a number of years with an apparently complete arrest of the neoplastic process and yet there are cases where a local recurrence develops twenty and even fifty years after operation. In most cases, when surgical treatment is indicated, wide excision gives longer periods of remission and more often leads to permanent arrest of the disease, than less agressive or conservative operations. Before submitting a patient to surgical treatment it is essential to define clearly the criteria ofoperability. Technical operability is not sufficient. Haagensen of the Presbyterian Hospital, New York, postulated such criteria in breast cancer and considered as 'categorically inoperable' all cases who did not comply with the assessment of these criteria although technically many of these patients were operable. Such criteria can of course be applied to many other sites, for instance, the neck in connexion with a radical block dissection. These criteria do vary with the individual surgeons, but should only do so within definite and somewhat narrow limits. This self-imposed discipline is of primary importance if the results of surgical excision for cancer are to be improved.
The limitations of surgery in the treatment of cancer are twofold: the limitations of surgery as a skill and the limitations of the surgeon as an individual.
The limitations of surgery are those imposed by the natural history of the tumour, its mode of spread and by the stage at which the patient seeks advice. Examples of such limitations are plentiful, such as the metastatic supraclavicular nodes in cancer of the lung or stomach, or the presence of cedema in breast cancer.
There is, however, in selected cases a place for extensive surgery even in the presenice of visceral metastases; in such cases surgery is of palliative value but is none the less justifiable and may temporarily alter the course of the disease, prolong the survival period and limit the miseries of the terminal stages. It is not infrequently indicated in cancer of the stomach, the colon and the kidney.
To define the limitations of the surgeon as an individual needs a little more elaboration. Such limitations as a rule are not due to lack of technical ability. The surgical performance may be above all criticism, and yet the result will be an aggravation and not an amelioration of the patient's state. Such limitations may be due to a lack of long-term experience, but mostly they are due to confusion of thought and lack of a strict surgical discipline. A common example is surgery of breast cancer. Much has been made of the controversy between 'radical mastectomy' and 'simple mastectomy and radiotherapy', but this has only led to greater confusion and has certainly retarded progress. The figures put forward as evidence for the achievement of simple mastectomy and radiotherapy are not convincing, sometimes nmisleading and when looked at critically meaningless, as the material compared is in fact not comparable. On the other hand the large series of cases reported from reliable sources show that 80 % of patients with a stage 1 and grade 1 breast cancer submitted to radical mastectomy survive at least five years and 65 % may reach a ten-year survival period. No comparable reliable figures are available for simple mastectomy and radiotherapy. There is, however, abundant evidence that both methods fail to control the disease when applied to unsuitable cases. To operate by whatever method on late stage 2 or stage 3 cases of breast cancer not only fails to control the disease but definitely worsens the patient's state. In such patients mastectomy, simple or radical, promotes local spread of the disease as can be witnessed in any radiotherapy centre when patient after patient is seen with local recurrences, cancer en cuirasse, extensive nodules, ulceration, gross oedema of the arm, and fixed regional lymph nodes. These human wrecks are not merely the victims of cancer but equally the victims of misguided therapy. Strict criteria of operability would alter the picture and without surgery such patients would benefit from radiotherapy and hormone therapy to a much greater degree. There is considerable evidence that cancer can be seeded by the surgical act, not only in the case of the breast but in other sites, such as the urinary bladder, in laparotomy scars and in malignant melanoma; this is a local implantation of cancer cells. But there is also evidence that surgery, if ill-timed, can accelerate or promote the development of distant bloodborne metastases. The rapid appearance of multiple pulmonary metastases following a hasty amputation for an osteogenic sarcoma has been noted many years ago. Ferguson (1940) , in an analysis of 400 cases of osteogenic sarcoma, separated them in two groups. Those where amputation was performed within the first six months from the onset of the disease ('early amputation') gave only 5 % with five years' freedom from symptoms. In the case where the amputation was delayed for more than six months 34% were free from symptoms for five years. Amputation of a limb for osteogenic sarcoma should be done in a quiescent phase of the disease. Such a dormant state can be induced by local radiotherapy which influences the liability of metastatic spread; yet there are still a number of surgeons who practise ablation of limbs as the first and immediate and only measure with the same paucity of results now as fifty years ago.
The usual practice in the case of Wilms' tumours is to operate at once, almost as an emergency measure, and then refer the child for post-operative radiotherapy. That this common practice of immediate and urgent surgery is not effective is evidenced by the small number of children so treated who reach adult life or even adolescence. Yet Wilms' tumour is supremely radiosensitive and the response to radiation is enhanced by suitable concomitant chemotherapy, such as actinomycin D. Massive tumours, often filling a large part of the abdomen, regress rapidly and within a few weeks of such combined therapy nephrectomy becomes simple, easy and far less traumatizing; whereas attempts at the removal of large, tense, vascular tumours spread the disease by the blood stream and do so rapidly. Many other examples could be given of bad timing of the surgical act, of poor selection of patients, of lack of combined treatment.
The results of surgery in suitable cases have not been surpassed by other methods of treatment but there is no room for complacency and ample room for improvement. Fewer cancer patients would be submitted to operation, but to a better purpose if selection and timing were based on the life history of the tumour and not on the feasibility of its ablation. Another example of the surgeon failing, due to confusion of thought, is the so-called conservative or 'modified' operation, which is inevitably a compromise.
Such is the conservative operation for low, rectal cancer, when the primary aim of conserving the patient is lost sight of, by the obsession for conserving the anal sphincters. The attempt at a half-way house between a radical and simple mastectomy, when the pectoral muscles are not removed, is a further example; I believe that an adequate and accurate clearance of the axilla is more likely to be achieved when the pectoral muscles are removed than when they are preserved.
Such errors of commission or omission are not due to bad technique but to bad surgical judgment, which defeats the very object of submitting the patient to an ordeal so eloquently expressed by Lord Moynihan (1928) in an address to students: 'For us an operation is an incident in the day's work, but for our patients it may be, and no doubt often is, the sternest and most dreaded of all trials, for the mysteries of life and death surround it and it must be faced alone.' Of the surgeon's character, thoughts and burdens Sir Russell Brock (1962) with equal eloquence speaks as follows: '. . . he must, if he is to succeed, possess certain high qualities of feeling, and certainly he must possess a wholly intelligent approach to his subject and if possible a highly scientific one.'
To quote once again Professor Smithers (1960) : 'It is no great tribute to the art of surgery to see a feeble old gentleman dragging out his life for a few months cured of an advanced pharyngeal carcinoma if deprived of many things which might have made these few months tolerable. It may, however, be of inestimable value to a young woman with a family to be alive following a total pelvic exenteration, if she has the stamina and the courage to sustain her greatly altered life.'
You may think that I am lacking in magnanimity, that I might be, or should be, a little more generous to surgeons at large, that good fortune gave me opportunities, denied to many, to spend my professional life in an ambiance of colleagues, facilities, equipment and opportunities somewhat more generous than the average, and that all this should make me more restrained in my criticisms. But such magnanimity would be based on lack of courage or even cowardice to speak the truth as it appears to me in the light of everyday experience. Such restraint would be illogical if the main purpose of therapy is to 6 Proceedings ofthe Royal Society ofMedicine salvage a few more, perhaps many more, than are salvaged to-day from the inevitable destiny facing a cancer patient.
My critical observations on the practice of surgery in cancer are made without malice but in the hope that the contribution of this Nuffield Lecture, endowed for the specific purpose of the advancement of medicine, may be to translate what is still a cry in the wilderness into a policy of surgery founded not on the capability of a pair of hands to remove viscera, limbs, breasts but on an accurate critical faculty, based on the complementary knowledge of the disease and the limitations of any particular form of treatment.
Radiotherapy
The achievement of radiotherapy is great indeed and the speed of its development is equally remarkable. But it had its years of pioneering and exploration which have come to the 'end of the beginning', by the availability of megavoltage apparatus. In practice a much greater number of cancer patients can benefit from radiotherapy than from surgery. As a palliative weapon it has immense value, as a curative measure it can control some tumours when surgery is harmful, ineffective or impracticable. The selection of patients for radiotherapy requiires the same accuracy and knowledge as the selection for surgery and equally great skill is needed in the detail of technique, in timing, dose, dose-rate, overall time, &c. But, like surgery, so radiotherapy can do harm by lowering the local resistance. Painful radionecrosis of the jaws, the shrunken fibrosed bladder euphemistically referred to as the 'systolic bladder', which renders the patient's life almost unbearable, the local skin recurrences exactly within the pigmented telangiectatic area following the so-called 'conventional' X-ray therapy; these unfortunately are not mere accidents but often the result of routine treatment.
Radiotherapy has an increasing potential of achievement with the availability of megavoltage and megacurie apparatus, with the nearly perfect precision of beam direction and the fractionation of dosage over longer overall periods of treatment. These advances have altered the meaning of the attribute 'radioresistant'. Bone and soft tissue sarcoma, irremovable adenocarcinoma of the bowel or ovaries are no longer resistant to the modern radiotherapy methods, either alone or in combination with chemotherapy.
The Promise of Chemotherapy The great attraction of chemotherapy is that it is a systemic attack on cancer. It is still in its early stages of development, both as regards the compounds used and the techniques employed. But already it is recognized that certain cytotoxic agents have a selective action on certain tumours. To the original nitrogen mustard used in Hodgkin's disease and the reticuloses has been added a series of chemotherapeutic agents. Busulphan in chronic granulocytic leukemia, chlorambucil in chronic lymphocytic leukmemia, 6-mercaptopurin in acute leukeemia in children, melphalan in multiple myeloma and malignant melanoma, methotrexate in chorioncarcinoma, teratoma of testes and squamous cell carcinoma of the mouth, and acute leuk2emia in children. These and many other anti-neoplastic agents fall into two main groupsthe alkylating agents and the antimetabolites. Their mode of action is somewhat different and hence a combination of both groups may prove of interest.
The screening of thousands of antibiotics for anticancer activity has added so far two compounds, actinomycin D and mitomycin C whose tumour-inhibitory action has been used clinically. Actinomycin D has proved of considerable value in Wilms' tumour, synovial sarcoma and rhabdomyosarcoma, especially in conjunction with radiotherapy, as, besides its direct effect, it increases the radiosensitivity of tumours.
A very large number of plant extracts have been examined for possible antitumour action. Of these, derivatives of natural or synthetic colchicine such as N-desacetyl-thiocolchicine, unlike most other agents, have a controlling effect on adenocarcinoma of the ovary and the bowel. More recently vinblastine, an alkaloid derived from the periwinkle, has proved of interest in the terminal stages of Hodgkin's disease and of melanoma.
The clinical use of chemotherapy requires specialized knowledge not only of the various available drugs but of methods of administration and dosage. Certain general principles must be observed in the practical application of the variety of drugs available. There is a narrow margin between the desirable effect on the tumour and the toxic effect on the patient. Bonemarrow depletion, hematopoietic depression, undesirable side-effects on mucous membranes, severe gastrointestinal upsets, are some of the side-effects which occur if the dosage used is to result in tumour regression. Many of the cytotoxic agents are chemically unstable and are excreted or detoxicated rapidly. To ensure an effective concentration of the active drug in the tumour and yet minimize the general undesirable effects, new techniques have been developed. The perfusion of limbs or organs permits the administration locally of doses which would be lethal if they were to reach the general circulation. Intra-arterial infusion at the nearest point to the tumour-bearing area permits the continuous or intermittent administration ofthe chosen cytotoxic agent over long periods of days or even weeks and an enhanced effect of the drug is obtained.
The advances in techniques of administration, the availability of an increasing number of drugs, the more effective and more rapid screening methods have resulted in a widening of the field of usefulness of chemotherapy in the treatment of cancer. It is no longer the last resort to be used only in the most advanced or otherwise untreatable cases. In some forms of neoplastic disease it is the remedy of choice: in the leuktemias, multiple myeloma, chorionepithelioma. In other varieties of cancer chemotherapy is part of a combined treatment by surgery or radiotherapy, or both, even in early cases. In patients with disseminated cancer it may be of considerable palliative value. The effectiveness of a given drug may also depend on the dosage programme and the time intervals between the administration of the drugs. Different tumours require not only different drugs but different schedules of treatment. The results of chemotherapy can also be improved or the period-of effectiveness prolonged by the combination of several drugs. These should be chosen for their difference of mode of action and given either together to potentiate one another or in sequence to overcome drug resistance. The use of specific antidotes such as folinic acid and methotrexate, the preservation of autologous bone marrow with a view to marrow transfusion are refinements which permit a more radical chemotherapeutic attack.
The Fascination of Hormone Therapy Hormonal control of cancer is the most exciting event in the realm of tumour biology. The concept that cancer is an irreversible state, independent and uncontrollable, is obviously no longer true. It can be controlled by physiological means; it is dependent on normal phenomena; it relies on its environment for survival. This concept of hormone dependence has led to an entirely new method of treatment. To the time-honoured methods of treatment -'cut it -out', 'burn it out', 'poison it', methods which aimed at the direct attack on cancer with the object of destroying ithas been added an indirect attack, the weapon of physiological warfare against cancer. By altering the hormonal environment of the patient, the persistence or survival or rate of growth of cancer can be profoundly affected. In the history of medicine this is the first indirect attack on malignant tumours.
Admittedly it is applicable only to cancer of the breast and prostate and possibly in an indirect way to the lymphomas. Admittedly not all mammary cancers are dependent on the hormonal environment and, again admittedly, although the effect of such altered hormonal state on the control of cancer is not permanent but reversible, it still remains the greatest advance made so far.
A tribute should be paid to two men who contributed to this new knowledge: To Sir Charles Dodds, who by the synthesis of stilbcestrol put this new tool in the hands of research workers and clinicians, and to Charles Huggins, who by his designed, not accidental, discoveries proceeded from orchidectomy and oestrogens in the treatment of prostatic cancer to adrenalectomy in disseminated breast cancer.
The hormonal control of cancer of the breast and prostate can be achieved by several different ways: by the administration or by the withdrawal of sex hormones; by surgical or medical methods. Hormonal control of prostatic cancer is now the universally accepted method of treatment. Hormonal control of breast cancer is reserved for the late case, mostly disseminated, but could and will be extended to earlier stages of the disease. In the treatment of widely disseminated mammary cancer there is no other weapon which. can be used with comparable effectiveness, to control the progress of the disease, to relieve pain and prolong life.
The Combined Treatment of Cantcer
There are now at the disposal of the cancer patient four methods of treatment: surgery, radiotherapy, chemotherapy and hormone therapy. Each has an important place and each has its limitations. These methods are not competitive but complementary. They can be used separately, concomitantly or in sequence. The indications for such combinations and sequences are not always appreciated and their timing requires skill and knowledge.
A few examples will illustrate the possible varieties of combined treatment. In cancer of the tongue, the primary growth can be completely regressed by radiation and the lymph-node metastases by surgical excision. In malignant testicular tumours the reverse is practised, orchidectomy followed by radiotherapy to the regional lymph nodes. In malignant melanoma, chemotherapy is used as an adjunct to surgery or as the sole method of treatment according to the stage of the disease. In cancer of the breast, stage and grade of the disease are the main guides to the therapeutic attack by surgery or radiation or both, by surgery and hormones, or by hormones and radiotherapy. In advanced inoperable ovarian cancer, a simultaneous attack by radiotherapy and chemotherapy may lead to a degree of regression which permits surgery. An unbiased assessment of the possible combinations of treatment shows clearly the need of a team of specialists. Such a team of varied skills, which must include not only general and specialist surgeons, radiotherapists and physicians but equally biochemists, organic chemists and physicists, should work in complete co-operation. Such teams exist and have existed for many years. Their success is recognized by the continued stream of patients such combined clinics attract. If a cancer patient has the good fortune to be referred to a hospital where such a team exists, he has a better chance of cure or palliation than the patient whose fate is in the hands of one individual and whose treatment is determined fortuitously by the specialty of the department he is sent to.
Cancer Education
Cancer education has its advocates and its opponents. It is still a controversial subject, although less so than a decade or two ago. The views on education vary from being just a part of health education and hygiene in general, to the sustained and specific object of telling all those who care to listen all sorts of things about cancer. But fundamentally the object of educating the population at large in matters of cancer is to achieve earlier diagnosis, in the belief that early diagnosis will lead to better control of the disease. This, of course, does not apply to all cancers but only to some of them. An aggressive policy has been pursued by the American Cancer Society: posters, films, pamphlets, lectures, broadcasts, television; man, woman and child have become familiar with slogans, the seven deadly signs, graphs, figures of mortality, these always climbing towards the sky-line. What has all this achieved? Something substantial no doubt, but not what it set out to achieve. It achieved the provision of vast sums of money for research, for the care of patients, special children's institutions, the popularization of the Papanicolaou's cytological diagnosis. It has achieved something else, more important, a familiarity with the word 'cancer', the acceptance of cancer as a common disease, a familiarity with the dreaded enemyand hence perhaps less fear and less despondency, a lesser reluctance to submit to treatment. These are considerable achievements, but all this propaganda has failed in the major issuewhich is to lessen mortality and morbidity and to prolong survival. I believe that education of the public is of value but far less value than the education of the medical student and doctor.
Self-examination of the breast, the cherished hobby of some, is less likely to gather early cases than the inculcation of basic principles of diagnosis into the doctor. For every woman who by self-examination discovers a lump in her breast there are hundreds if not thousands who discover it accidentally, casually. What happens to these women? Some ignore itthis could be improved by lessening the element of fear; others go to their doctors, and may be told and not unfrequently are told to keep it, the diagnosis being 'mastitis' or even more facile 'this is nothing'. Surely the first principle in cancer education is, to the doctor, that a 'lump' or an 'ulcer' is 'something' and not just 'nothing'; that being potentially lethal, its nature must be ascertained. To find a lesion and to be advised to do nothing about it, is as great a misfortune as to be unaware of the lesion. In brief, at this stage more could be gained by a greater 'cancer consciousness' of doctors than by any other means. Perhaps there is something missing in our medical education? Do we lack the logic to draw the right conclusions from the obvious physical signs, or the courage to interpret the patient's story and the abnormalities found on examination, till there is no longer any hope of avoiding the diagnosis of cancer? Is it not our duty to fear the worst, not to run away from it, but to face it? Is it still excusable to talk about 'change of life' in postmenopausal bleeding, or of 'piles' in persistent rectal heemorrhage without investigation or even examination of the patient? The average delay in diagnosis to-day is weeks and months, as it was years ago. The few patients who by public propaganda are induced to seek early advice are as nothing to the many who do so and are not given it.
As a surgeon I would like to conclude this third Nuffield Lecture by quoting the remarks of that great British surgeon, eloquent of speech, broad in mind, kind in nature, skilful in execution and courageous in his approach to cancer surgery -Gordon-Taylor: '. . . "the vision splendid", which for us is that longdesired day, perhaps not too far distant, when in the cure of cancer gross mechanical destruction and cruel mutilation of human tissues shall no longer be required, nor the scorching methods and machinery of Hephaestus the blacksmith god, or Prometheus who stole fire from heaven! "When the biologist shall know the laws that govern cell-growth with a knowledge akin in its sweep and accuracy to that of the astronomer", he will then have a power denied to those who scan the stars in the firmament, and that power will enable him to prevent, to control, and to cure cancer.' (Gordon-Taylor 1948) 
